Condition: Osteoarthritis, Knee · Joint Diseases · Rheumatoid Arthritis of Knee · Sponsor: Aesculap AG
The purpose of this PMCF study is to demonstrate the accuracy of navigation using the new pheno4uTKA Level 1 software for OrthoPilot Elite® and to evaluate its safety and performance. Patient-related outcome measures (PROM) will be acquired to investigate functional outcome and patient satisfaction.
This description comes directly from the study's public registry record.
Heike Oberascher · +49 7461 95 · studies@aesculap.de
Stefan Maenz, Dr. · +49 7461 95 · studies@aesculap.de
Always discuss trial participation with your own doctor first.
| Šumperk Hospital Inc. | Šumperk, Czechia | Not Yet Recruiting |
| Klinikum Konstanz GmbH | Konstanz, Baden-Wurttemberg, Germany | Not Yet Recruiting |
| Park-Klinik Weißensee | Berlin, Germany | Recruiting |
| Universitätsklinikum Carl Gustav Carus | Dresden, Germany | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06955481